LKB1 Mutation Status is Associated with Poor Radiation Outcome in Patients with Non-Small Cell Lung Cancer

被引：0
|
作者：
Sitthideatphaiboon, P. [1 ]
Cobo, A. [2 ,3 ]
Poteete, A. [2 ,3 ]
Zhang, F. [2 ,3 ]
Lui, D. [4 ]
Rinsurongkawong, W. [5 ]
Heymach, J. [6 ]
机构：
[1] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Div Med Oncol, Dept Med,Fac Med, Bangkok, Thailand
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Med Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Liver Kinase B1; Kelch-like ECH-Associated Protein 1; Radio-resistance;
D O I：
10.1016/j.jtho.2018.08.1705
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03-28
引用
收藏
页码：S921 / S921
页数：1
相关论文
共 50 条
  • [31] Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
    Tanaka, Ichidai
    Koyama, Junji
    Itoigawa, Hideyuki
    Hayai, Shunsaku
    Morise, Masahiro
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [32] Effects of phenformin in LKB1/KRAS mutated non-small cell lung cancer patient derived xenograft
    Moro, Massimo
    Roz, Luca
    Caserini, Roberto
    Pastorino, Ugo
    Sozzi, Gabriella
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer
    Gill, R. K.
    Yang, S-H
    Meerzaman, D.
    Mechanic, L. E.
    Bowman, E. D.
    Jeon, H-S
    Chowdhuri, S. Roy
    Shakoori, A.
    Dracheva, T.
    Hong, K-M
    Fukuoka, J.
    Zhang, J-H
    Harris, C. C.
    Jen, J.
    ONCOGENE, 2011, 30 (35) : 3784 - 3791
  • [34] Identification of DTYMK and CHEK1 as therapeutic targets in LKB1 mutant non-small cell lung cancer
    Liu, Yan
    Cowley, Glenn S.
    Cohoon, Travis J.
    Root, David E.
    Kwok-kin, Wong
    CANCER RESEARCH, 2012, 72
  • [35] The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
    Mograbi, Baharia
    Heeke, Simon
    Hofman, Paul
    DIAGNOSTICS, 2021, 11 (02)
  • [36] LKB1 mutation in large cell carcinoma of the lung
    Zhong, Diansheng
    Guo, Lizheng
    de Aguirre, Itziar
    Liu, Xiuju
    Lamb, Neil
    Sun, Shi-Yong
    Gal, Anthony A.
    Vertino, Paula M.
    Zhou, Wei
    LUNG CANCER, 2006, 53 (03) : 285 - 294
  • [37] Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
    Borzi, Cristina
    Galli, Giulia
    Ganzinelli, Monica
    Signorelli, Diego
    Vernieri, Claudio
    Garassino, Marina Chiara
    Sozzi, Gabriella
    Moro, Massimo
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 12
  • [38] LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
    Li, Fuming
    Han, Xiangkun
    Li, Fei
    Wang, Rui
    Wang, Hui
    Gao, Yijun
    Wang, Xujun
    Fang, Zhaoyuan
    Zhang, Wenjing
    Yao, Shun
    Tong, Xinyuan
    Wang, Yuetong
    Feng, Yan
    Sun, Yihua
    Li, Yuan
    Wong, Kwok-Kin
    Zhai, Qiwei
    Chen, Haiquan
    Ji, Hongbin
    CANCER CELL, 2015, 27 (05) : 698 - 711
  • [39] LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro
    Ping Xiao
    Lin-lin Sun
    Jing Wang
    Rui-li Han
    Qing Ma
    Dian-sheng Zhong
    Acta Pharmacologica Sinica, 2015, 36 : 1107 - 1112
  • [40] LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-Small Cell Lung Cancer Plasticity and Therapeutic Response
    Li, Fuming
    Han, Xiangkun
    Li, Fei
    Wang, Rui
    Li, Yuan
    Wong, Kowk-Kin
    Chen, Haiquan
    Ji, Hongbin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S473 - S474
12345